Evaluation of Some Extrinsic Factors Predisposing to Helicobacter Pylori-Associated Iron Deficiency Anemia
Main Article Content
Abstract
In the article, iron deficiency associated with Helicobacter pylori is associated with a number of external factors and bad habits in the development of anemia. Helicobacter pylori should be tested in all patients with chronic iron deficiency anemia and gastrointestinal complaints. In patients diagnosed with Helicobacter pylori-associated iron-deficiency anemia, it has been shown to have a highly reliable effect of first carrying out antibacterial eradication therapy and then prescribing an iron supplement according to the severity of the disease.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Andreeva T. I., Krasovsky K. S., Ananyeva G. A., Andreicheva E. N. Smokeless tobacco consumption is an additional problem of tobacco control in Russia // Narcology. - 2011. - No. 1. - p. 44-49.
II. Zhebrun A.B. Helicobacter pylori infection. - St. Petersburg: Phoenix; 2006.
III. Ismailova Zh.A. Optimization of eradication therapy for Helicobacter-associated gastric disease, taking into account genetic virulence factors, dissertation for the degree of Doctor of Medical Sciences (DSc). 2022.
IV. Karimov M.M., Sobirova G.N., Saatov Z.Z. et al. Prevalence and molecular genetic characteristics of Helicobacter pylori in Uzbekistan // Effective Pharmacotherapy. 2019. V. 15. No. 28. -p. 48-51.
V. Kolosova N.G., Bayandina G.N., Mashukova N.G., Geppe N.A. Iron metabolism in the body and ways to correct its disorders. Difficult patient 2011; 8-9:54-58.
VI. Новик А.А., Богданов А.Н. Анемии (от «А» до «Я»). СПб: Нева 2004.
VII. Reshetnikov O.V., Kurilovich S.A., Krotov S.A. [et al.] The prevalence of atrophic gastritis in different populations of Siberia according to serological data // Clinical Medicine. - 2008. - No. 7. - p. 35–38.
VIII. Reshetnikov O.V., Kurilovich S.A. The prevalence of helicobacteriosis in some regions of Siberia according to serological studies // Journal of Microbiology, Epidemiology and Immunobiology. - 2000. - N 3. - p. 32–34.
IX. Цуканов, В. В. Эпидемиология язвенной болезни / В. В. Цуканов, О. В. Штыгашева, С. В. Баркалов. – Красноярск, 2004. – 213 с.
X. Amarapurkar D.N., Amarapurkar A.D. Intrinsic factor antibody negative atrophic gastritis; is it different from pernicious anaemia? Trop Gastroenterol 2010; 31 (4): 266—270.
XI. Association of IL1B -511C/-31T haplotype and Helicobacter pylori vacA genotypes with gastric ulcer and chronic gastritis [Электронный ресурс] / D. N. Martínez-Carrillo, E. Gar131 za-González, R. Betancourt-Linares [et al.] // BMC Gastroenterol. – 2010. – Vol. 10, №126.
XII. Epidemiological characteristics of Helicobacter pylori infection in Moscow / S. V. German, I. E. Zykova, A. V. Modestova [et al.] // Gig. Sanit. – 2011. – № 1. – P. 44–48.
XIII. Frenck. R., Clemens J. Helicobacter in the developing world // Microb. Infect. – 2003. – Vol.8.–N 5.–P. 705–713. doi: 10.4103/1319-3767.54743.
XIV. Gastroduodenitis and Helicobacter pylori in Nigerians: histopathological assessment of endoscopic biopsies / K. B. Badmos, O. S. Ojo, O. S. Olasode [et al.] // Niger. Postgrad. Med. J. – 2009. – Vol. 16, № 4. – P. 264–267.
XV. Helicobacter pylori infection in symptomatic patients with benign gastroduodenal diseases: analysis of 5.664 cases / J. P. Ortega, A. Espino, B. A. Calvo [et al.] // Rev. Med. Chil. – 2010. – Vol. 138, № 5. – P. 529–535.
XVI. Hershko C., Ronson A. Iron deficiency, Helicobacter infection and gastritis. Acta Haematol 2009; 122 (2—3): 97—102.
XVII. Fayed S.B., Aref M.I., Fathy H.M. et al. Prevalence of celiac disease, Helicobacter pylori and gastroesophageal reflux in patients with refractory iron deficiency anemia. J Trop Pediatr 2008; 54 (1): 43—53.
XVIII. Hershko C., Skikne B. Pathogenesis and management of iron deficiency anemia: emerging role of celiac disease, Helicobacter pylori, and autoimmune gastritis. Semin Hematol 2009; 46 (4): 339—350.
XIX. Isolation of Helicobacter pylori in gastric mucosa, dental plaque and saliva in a population from the Venezuelan Andes / L. De Sousa, L. Vásquez, J. Velasco [et al.] // Invest. Clin. – 2006. – Vol. 47, № 2. – P. 109–116.
XX. Kodama M., Murakami K., Okimoto T. et al. Helicobacter pylori eradication improves gastric atrophy and intestinal metaplasia in long-term observation. Digestion 2012; 85 (2): 126—130.
XXI. Malaty H., Paykov V., Bykova O. Helicobacter pylori and socioeconomic factors in Russia // Helicobacter. – 1996. – N 1. – P. 82–87.
XXII. Malfertheiner P., Megraud F., O’Morain C.A. et al. Management of Helicobacter pylori infection — the Maastricht IV/ Florence Consensus Report. Gut 2012; 61 (5): 646—664.
XXIII. O'Connor A., Gisbert J.P., McNamara D., O'Morain C. Treatment of Helicobacter pylori infection 2010 // Helicobacter. 2010. Vol. 15. Suppl. 1. P. 46–52.
XXIV. Prevalence of Helicobacter pylori infection, chronic gastritis, and intestinal metaplasia in Mozambican dyspeptic patients / C. Carrilho, P. Modcoicar, L. Cunha [et al.] // Virchows Arch. – 2009. – Vol. 454, № 2. – P. 153–160.
XXV. Rothenbacher D., Brenner H. Burden of H. pylori and diseases in developed countries; recent developments and future implications // Microb. Infect. – 2003. –Vol.8. – N 5. – P. 693–703.
XXVI. Safonova N., Zhebrun A., Noskov F.Th e role of helicobacteriosis in the gastro–enteropathology in Saint–Petersburg // Helicobacter pylori and the new concepts in gastro–duodenal disease. Charles University, Prague–Chechoslovaria. – 1992. – P.31.
XXVII. Seroprevalence of Helicobacter pylori in dyspeptic patients and its relationship with HIV infection, ABO blood groups and life style in a university hospital, Northwest Ethiopia / F.Moges, A. Kassu, G. Mengistu [et al.] // World J. Gastroenterol. – 2006. – Vol. 12, № 12. – P. 1957–1961.